Research in Society 2017-2018 programme kicks off Blog Post

Today, Monday 10 July, the Barcelona Science Park (Parc Científic de Barcelona, PCB) has kicked off its 17th Research in Society programme with the opening of the pre-registration period for the experimental workshops “Discover research!” and “Do research!”. This year, for the first time, places will be allocated to applicant schools in a draw using the list of reservation numbers.

 

Boosting natural detoxification pathways in the body to reduce cellular oxidative stress Blog Post

Promoting innate detoxification mechanisms in the body and discovering which supplements increase the efficacy of those biochemical pathways could be an efficient strategy to reduce the cellular oxidative stress and protect our health, according to an article published in the journal Food Chemistry, by the researchers Rafael Franco, from the Institute of Biomedicine of the University of Barcelona at the Barcelona Science Park and Eva Martínez Pinilla, from the Institute of Neurosciences of Asturias (INEUROPA) and the University of Oviedo.

 

Researchers from IBUB create a new technique to measure brown adipose tissue activity Blog Post

Experts from the Institute of Biomedicine of Barcelona (IBUB), located at the Barcelona Science Park (PCB) have created a new technique to measure the energy production and use in brown adipose tissue, a key organ in obesity due its capacity to oxidize fat and dissipate energy as heat. This method, published in the scientific journal Advanced Science, improved the precision of previous techniques to fight obesity. 

 

Fresh financial and institutional support for the Research in Society programme Blog Post

Once again the ‘Research in Society’ programme run by the Barcelona Science Park (Parc Científic de Barcelona, PCB) will have the financial backing of the Spanish Foundation for Science and Technology (Fundación Española para la Ciencia y Tecnología) and Barcelona City Council in the shape of grants coming to €23,000 and €16,700 respectively. This funding from the two institutions will help secure the development of the PCB’s science popularisation activities and also recognises its firm commitment to driving measures that add to the social dimension of science.   

 

Minoryx successfully completes phase 1 clinical trial for lead candidate MIN-102 Blog Post

Minoryx Therapeutics – a drug development company specialized in the discovery and development of new drugs for orphan diseases, which has R& D laboratories at the Barcelona Science Park– announces that it has successfully completed its phase 1 trial with its lead compound MIN-102 targeting X-linked adrenoleukodystrophy (X-ALD), a life threatening orphan CNS disease with high unmet medical need.

 

CataloniaBio grants the ‘BioSuccess of the Year’ award to STAT-Diagnostica Blog Post

The Catalan Association of Biotechnology Companies (CataloniaBio) has recognized Stat-Diagnostica –founded in 2010 at the Barcelona Science Park by Jordi Carrera and Rafael Bru– with the ‘Biosuccess of the Year’ Award. The prize giving ceremony was held yesterday at the Museu Maritimo of Barcelona under his winter networking event CataloniaBio Gala Dinner, a yearly meeting organised by this business association with the aim of enhancing scientific-business cooperation in Catalonia in the field of life sciences and health.

 

Dr Thomas Högberg to head up Mind the Byte office in Scandinavia Blog Post

Mind the Byte, located at the Barcelona Science Park, continues to reinforce its international presence. To this end, Thomas Högberg is joining the company as Business Development Director Scandinavia and Senior Advisor in order to consolidate computational design services in one of the most important pharmaceutical and biotechnology markets in Europe. He will carry out these responsibilities from the company’s offices at the Copenhagen Bio Science Park (COBIS).

 

How tumor cells hijack healthy cells to promote metastasis Blog Post

A team of researchers led by Xavier Trepat –ICREA research professor at the Institute for Bioengineering of Catalonia (IBEC) based at PCB– has identified a mechanism by which cancer cells manage to escape the tumor to promote metastasis. The study, which was published today and will be on the cover of the prestigious journal Nature Cell Biology (doi:10.1038/ncb3478), and has been supported by the Obra Social “la Caixa”, revealed that tumor cells can reprogramme their healthy neighbours, dragging them out of the tumor and into other tissues.

 

Cebiotex raises a € 1.8 million in second funding round Blog Post

Cebiotex –a spin-off of the Hospital Sant Joan de Déu in Barcelona (HSJD) and the Universitat Politècnica de Catalunya (UPC) based at the Barcelona Science Park (PCB)– has closed a funding round totaling € 1.8 million. that will allow the company to complete the regulatory pre-clinical phase of post-surgery cancer treatment for soft tissue sarcomas CEB-01. This is the first therapeutic indication developed by its innovative technology platform Cebiotex®, based on biomedical application of nanofibers for the local delivery of drugs (Local Drug Delivery System).